Back
  • Poster
  • IIP 261

Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
Poster 4

Poster

Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster

Topic

  • Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)

Authors

Isabell Wagenhäuser (Würzburg, DE), Julia Reusch (Würzburg, DE), Alexander Gabel (Würzburg, DE), Juliane Mees (Würzburg, DE), Lukas Krone (Oxford, GB; Bern, CH), Oliver Kurzai (Würzburg, DE; Jena, DE), Nils Petri (Würzburg, DE), Manuel Krone (Würzburg, DE)

    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy